Transparency Sought From FDA In GRAS Notification Filing Decisions

FDA should clarify its criteria for rejecting generally recognized as safe notifications for food ingredients voluntarily submitted by companies, a consulting firm tells the agency.

More from Archive

More from Pink Sheet